Roberta Kiffin

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 10, 2024
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.

Hanna Grauers Wiktorin, Ebru Aydin, Roberta Kiffin

|Jan 24, 2022
Impact of CYBA genotypes on severity and progression of multiple sclerosis.

Andreas Törnell, Roberta Kiffin, Sara Haghighi

|Apr 18, 2019
Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML.

Johan Aurelius, Lars Möllgård, Roberta Kiffin

|Oct 14, 2018
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.

Hanna Grauers Wiktorin, Malin S Nilsson, Roberta Kiffin

Pageof 1